Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Sponsor
Centre Hospitalier Universitaire de Besancon
Study ID
NCT04191395
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points. The pathologies concerned are inflammatory bowel diseases (IBD - Crohn's disease \[MC\] and ulcerative colitis \[RCH\]), chronic inflammatory skin diseases (psoriasis or Verneuil's disease) and chronic inflammatory rheumatic diseases (rheumatoid arthritis \[RA\] and spondyloarthritis \[SpA\] including psoriatic arthritis \[PsA\]). Presenting one of these diseases is associated with a higher risk of having a second inflammatory pathology, whether the latter is ophthalmological, dermatological, rheumatological or gastroenterological. An association of extra-articular manifestations is observed in 10 to 30% of patients with SpA, and an association of extra-intestinal manifestations is observed in approximately 30% of patients with IBD. No common database for chronic systemic inflammatory diseases currently exists in France.

Key Dates

First listed
Dec 9, 2019
Start date
Dec 11, 2019
Status verified
Nov 2024
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
3,000 participants (estimated)

Arms

  • Arm: Inflammatory bowel disease
  • Arm: Chronic inflammatory rheumatic disease
  • Arm: Chronic inflammatory skin diseases

Primary Outcome Measure

Diagnosis of a second inflammatory disease [ Time Frame: through study completion (up to 10 years) ]

Central Contacts

  • Charline Vauchy, PhD
    0381218875
    [email protected]
  • Stéphanie François
    sfrancois@chu-besançon.fr

Find similar trials

Nationwide
Rheumatoid arthritis trialsCrohn's disease trialsPsoriasis trialsPsoriatic arthritis trialsUlcerative colitis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trialsGastroenterology trialsInflammatory bowel disease trialsDermatology trials

Related Studies